Skip to main content

Third Wave Closes $14.9M Convertible Notes Placement

NEW YORK (GenomeWeb News) — Third Wave Technologies has pocketed $14.9 million after closing the sale of its previously announced zero-coupon convertible notes, the company said today.
 
Third Wave said it intends to use the cash infusion for general corporate expenses.
 
Third Wave said it would place the notes with an unnamed institutional investor on Dec. 19.
 
The 6-percent notes, which are convertible into roughly 2.5 million shares, will be due in 2011 and are priced at an initial rate of $6 apiece.
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.